Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Wenzhou Kangning Hospital Co., Ltd.

Wenzhou Kangning Hospital Co., Ltd. (2120.HK)

Industry: Medical - Care Facilities Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $10.95 — $41.76
Selected (Average) $28.99
Upside to Live 194.30%
Full Range Fair Value
Range (Low - High) $14.94 — $51.68
Selected (Average) $38.42
Upside to Live 290.01%
Live Price $9.85

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
TVTY 92 Tivity Health, Inc 501 18.47 16.37 12.20 12.20 30.71 13.34
3309.HK 93 C-MER Medical Hold 492 - - 4.53 3.11 6.86 26.11
6639.HK 94 Arrail Group Limit 473 - - - - 27.32 -
3886.HK 95 Town Health Intern 469 - - 4.44 4.44 4.12 3.36
TOI 96 The Oncology Insti 461 - - - - - -
DVCR 97 Diversicare Health 460 4.66 4.66 7.35 5.22 - 30.47
CTH.L 98 CareTech Holdings 458 47.21 50.47 23.55 22.43 23.23 21.77
2120.HK 99 Wenzhou Kangning H 456 4.52 4.15 3.39 2.72 8.41 7.96
MEDANTA.BO 100 Global Health Limi 443 62.92 62.92 35.13 35.13 49.02 37.89
9530.SR 101 Arabian Internatio 440 - - 9.31 9.31 - 19.81
0383.HK 102 Tian An Medicare L 418 16.32 22.36 2.53 2.84 6.60 6.70
600763.SS 103 Topchoice Medical 416 38.13 37.30 26.70 26.06 19.55 28.12
3869.HK 104 Hospital Corporati 411 25.57 25.57 6.47 6.47 9.22 8.23
CSU 105 Capital Senior Liv 411 - - - - - -
KRSA3.SA 106 Kora Saúde Partic 410 - - 10.90 10.90 10.81 13.11
2219.HK 107 Chaoju Eye Care Ho 395 4.77 4.77 2.62 2.62 3.10 3.47

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple17.3919.366.915.859.2213.23
Full Range Median Multiple22.0223.978.337.8910.8116.58
Industry Multiple27.2628.0512.1411.7317.3217.70
Market Implied Multiple4.994.573.542.838.788.30
Company (2120.HK) Multiple4.524.153.392.728.417.96
(*) Net Income / EBITDA / Revenue202264802627
Winsorized Enterprise ValueN/AN/A445470239363
Full Range Median Enterprise ValueN/AN/A536634281455
(-) Net Debt126126126126126126
Winsorized Equity Value356433319344113237
Full Range Median Equity Value451536410509155329
(/) Shares Outstanding101010101010
Winsorized Fair Value$34.36$41.76$30.77$33.21$10.95$22.89
Full Range Median Fair Value$43.50$51.68$39.57$49.04$14.94$31.76
Current Price$9.85$9.85$9.85$9.85$9.85$9.85
Upside / Downside248.86%323.91%212.42%237.11%11.12%132.37%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$24.05$29.23$21.54$23.24$7.66$16.02
Buy / Don't BuyBUYBUYBUYBUYDon’t BuyBUY